Parkinson's Disease Trial, Recruiting NCT07378813 Sponsor: University of Miami Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT07378813
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with Parkinson's Disease at an early to middle stage (stages 1 to 3 on a standard scale used by doctors)
  • You are able to walk 50 metres (roughly the length of half a football pitch) on your own without help
  • You are able to understand and have a conversation in English
  • You have scored above 18 on a memory and thinking test called the MoCA, which means your thinking and memory are mostly intact (confirm with trial site)

Who may not be able to join:

  • You have a heart condition or another condition affecting your muscles or nerves that is not well controlled and would stop you from taking part in a physical training programme
  • You have an ongoing condition where your immune system attacks your body, such as rheumatoid arthritis, or another serious illness that could affect your participation
  • You have an injury or have had surgery on your arms or legs that has not fully healed and would stop you from doing weight-based exercise

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Joseph F. Signorile, PhD, University of Miami

Phone: 3052844173

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
30 January 2026
Est. completion
30 May 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in neuromuscular performance as measured by 1-repetition maximum (1RM); Change in neuromuscular performance as measured by Power Production

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov